| 4708 |
MOLECULAR MEDICINE |
Transcription abnormalities potentiate apoptosis of normal human fibroblasts. |
1997-12-01 |
10.1007/bf03401721 |
Andera Ladislav, Wasylyk Bohdan |
| 4707 |
MOLECULAR MEDICINE |
Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. |
1997-12-01 |
10.1007/bf03401718 |
Fraefel Cornel, Jacoby David R., Lage Christopher, Hilderbrand Harold, Chou Janice Y., Alt Fred W., Breakefield Xandra O., Majzoub Joseph A. |
| 4706 |
THE ONCOLOGIST |
Positron Emission Tomography: Current Role for Diagnosis and Therapy Monitoring in Oncology |
1997-12-01 |
10.1634/theoncologist.2-6-381 |
Strauss Ludwig G. |
| 4705 |
MOLECULAR MEDICINE |
Transcription factor-based drug design in anticancer drug development. |
1997-12-01 |
10.1007/bf03401717 |
Papavassiliou Athanasios G. |
| 4704 |
RADIOTHERAPY AND ONCOLOGY : JOURNAL OF THE EUROPEAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY |
Quality assurance in conformal radiotherapy: DYNARAD consensus report on practice guidelines |
1997-12-01 |
10.1016/s0167-8140(97)00144-8 |
Kolitsi Zoi, Dahl Olav, Van Loon Ron, Drouard Jean, Van Dijk Jan, Ruden Bengt Inge, Chierego Giorgio, Rosenwald Jean Claude |
| 4703 |
THE ONCOLOGIST |
Understanding the Myelodysplastic Syndromes |
1997-12-01 |
10.1634/theoncologist.2-6-389 |
Kouides Peter A., Bennett John M. |
| 4702 |
JOURNAL OF RADIATION RESEARCH |
Abstracts of the 40th Annual Meeting of the Japan Radiation Research Society: Kyoto, November 5–7, 1997 |
1997-12-01 |
10.1269/jrr.38.255 |
|
| 4701 |
THE ONCOLOGIST |
Outpatient Management of Febrile Neutropenia: Should We Change the Standard of Care? |
1997-12-01 |
10.1634/theoncologist.2-6-365 |
Talcott James A. |
| 4700 |
THE ONCOLOGIST |
The Cost of Biological Terrorism |
1997-12-01 |
10.1634/theoncologist.2-6-351i |
Coffey Donald S. |
| 4699 |
THE ONCOLOGIST |
Clinical Use of Irinotecan:Current Status and Future Considerations |
1997-12-01 |
10.1634/theoncologist.2-6-402 |
Saltz Leonard B. |
